Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

Sejin Oh, Jeonghun Yeom, Hee Jin Cho, Ju Hwa Kim, Seon Jin Yoon, Hakhyun Kim, Jason K. Sa, Shinyeong Ju, Hwanho Lee, Myung Joon Oh, Wonyeop Lee, Yumi Kwon, Honglan Li, Seunghyuk Choi, Jang Hee Han, Jong Hee Chang, Eunsuk Choi, Jayeon Kim, Nam Gu Her, Se Hoon KimSeok Gu Kang, Eunok Paek, Do Hyun Nam, Cheolju Lee, Hyun Seok Kim

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy

Chemical Compounds